Newtonpedia ES
Home › Biology › Tumor protein p53
Tumor protein p53
Image: Wikimedia Commons
Biology · 1979

Tumor protein p53

A regulatory protein that controls the cell cycle and DNA repair, and is often inactivated in human cancers.

Year
1979
Section
Biology

History

The p53 protein is a transcription factor, meaning a molecule that switches specific genes on or off. It is known as the guardian of the genome because, when it detects DNA damage, it halts cell division to allow repairs or, if the damage cannot be fixed, directs the cell to self-destruct. When p53 fails, damaged cells may keep dividing unchecked and form tumours. More than half of human cancers are thought to involve changes in this gene or in its activity.

Before its discovery, biologists studied virus-induced tumours and looked for proteins that transformed cells produced in excess. In 1979 several research groups described a protein that bound the large T antigen of the SV40 virus, which transforms cells in culture, and that was more abundant in transformed cells than in normal ones. Its apparent mass on a gel was about 53 kilodaltons, which gave it its name. For years it was believed to be an oncogene, a gene that promotes cancer; only later did researchers show that in its normal form it acts as a tumour suppressor. That early confusion delayed understanding of its real role.

The protein has about 393 amino acids, the building blocks of proteins, arranged in several domains. One binds DNA and recognises specific sequences, another lets four molecules join into a tetramer, the active form that binds DNA, and others regulate its activity and entry into the cell nucleus. Its true mass is about 43.7 kilodaltons; the name reflects its apparent weight, because its high proline content slows its movement through a gel. In normal cells its level stays low, since the protein Mdm2 tags it for destruction. When DNA damage or other stress appears, p53 escapes this breakdown, accumulates and switches on its target genes.

Among these targets is p21, an inhibitor of cyclin-dependent kinases that blocks the G1/S transition, the point where a cell begins copying its DNA. Other genes activate repair enzymes, and some, such as BAX or PUMA, promote apoptosis, programmed cell death. It seems p53 binds more strongly to the promoters of repair genes than to those of apoptosis genes, so repair is attempted first, and only if the damage persists and the protein keeps building up does cell death take over. It can also induce senescence, a permanent halt to division. Its interactions with relatives p63 and p73, and the existence of several isoforms, variant forms with different parts, make the picture more complex.

Today p53 is one of the most intensively studied proteins in oncology. It serves as a marker in tumour diagnosis and prognosis, and researchers are developing drugs that restore its function in tumours where it is mutated or block the mechanisms that degrade it. It is also important in stem cell biology, where its level influences differentiation and reprogramming. Although its protective role is clear, excessive p53 has been linked to ageing, showing that the balance of this protein matters as much as its presence.

Timeline

  • 1979A protein that binds the SV40 large T antigen and appears in excess in transformed cells is described.
  • 1979It is named p53 after its apparent mass of about 53 kilodaltons.
  • 2005The first human p53 isoforms, variant forms with different parts, are identified.

Trivia and anecdotes

A mistaken oncogene

For years p53 was thought to promote cancer, but in its normal form it actually acts as a tumour suppressor.

A misleading name

Its name comes from an apparent weight that does not match its true mass of about 43.7 kilodaltons.

Other milestones in Biology